Go Pro
→ A new income category is drawing serious money - here's why (From Investors Alley) (Ad)tc pixel Free CYTK Stock Alerts

Cytokinetics (CYTK) News Today

Cytokinetics logo
$73.95 +2.02 (+2.81%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$74.00 +0.05 (+0.07%)
As of 05:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Cytokinetics Latest News

RBC Capital Keeps Their Buy Rating on Cytokinetics (CYTK)
September 3 at 8:52 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CYTK/pressreleases/4413603/rbc-capital-keeps-their-buy-rating-on-cytokinetics-cytk/
Goldman Sachs Reaffirms Their Buy Rating on Cytokinetics (CYTK)
September 2 at 10:51 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CYTK/pressreleases/4368594/goldman-sachs-reaffirms-their-buy-rating-on-cytokinetics-cytk/
Evercore ISI Remains a Buy on Cytokinetics (CYTK)
September 2 at 10:51 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CYTK/pressreleases/4376544/evercore-isi-remains-a-buy-on-cytokinetics-cytk/
Cytokinetics to Participate in September Investor Conferences
September 2 at 4:00 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/02/3355472/35409/en/cytokinetics-to-participate-in-september-investor-conferences.html
Insider Selling: Cytokinetics (NASDAQ:CYTK) Director Sells 5,000 Shares
September 2 at 5:22 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cytk-insider-buying-and-selling-2026-09-02/
HC Wainwright Reaffirms "Buy" Rating for Cytokinetics (NASDAQ:CYTK)
September 2 at 1:13 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30997639
Insider Selling: Cytokinetics (NASDAQ:CYTK) Director Sells $357,400.00 in Stock
September 1 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-cytokinetics-nasdaq-cytk-director-sells-35740000-in-stock-2026-09-01/
Cytokinetics (CYTK) Reaches A Phase 3 First In Non Obstructive HCM
September 1 at 10:23 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cytokinetics-cytk-reaches-phase-3-050509679.html
Cytokinetics (CYTK) Presents New Phase 3 Data, Is It Still 34% Undervalued?
September 1 at 10:23 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cytokinetics-cytk-presents-phase-3-130823981.html
Cytokinetics (NASDAQ:CYTK) CEO Robert Blum Sells 7,500 Shares
September 1 at 4:21 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cytk-insider-buying-and-selling-2026-09-01/
Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 7,500 Shares
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-cytokinetics-nasdaq-cytk-ceo-sells-7500-shares-2026-08-31/
Andrew Callos Sells 10,000 Shares of Cytokinetics (NASDAQ:CYTK) Stock
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-andrew-callos-sells-10000-shares-of-cytokinetics-nasdaq-cytk-stock-2026-08-31/
Cytokinetics’ Aficamten Hits Dual Phase III Endpoints in Non-Obstructive HCM
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-cytokinetics-aficamten-hits-dual-phase-iii-endpoints-in-non-obstructive-hcm-2026-08-28/
Cytokinetics (NASDAQ:CYTK) Earns Buy Rating from HC Wainwright
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-cytokinetics-nasdaq-cytk-earns-buy-rating-from-hc-wainwright-2026-08-31/
Cytokinetics (NASDAQ:CYTK) Stock Rating Lowered by Wall Street Zen
August 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30993376
Cytokinetics Announces Additional ACACIA-HCM and MAPLE-HCM Results Showing Aficamten Benefits Across Hypertrophic Cardiomyopathy Spectrum
August 29, 2026  |  quiverquant.comQ
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
August 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/29/3352934/35409/en/cytokinetics-announces-additional-results-from-acacia-hcm-and-maple-hcm-presented-in-late-breaking-clinical-trial-session-at-the-european-society-of-cardiology-esc-congress-2026.html
Cytokinetics (NASDAQ:CYTK) Downgraded to Sell Rating by Wall Street Zen
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-cytokinetics-nasdaq-cytk-downgraded-to-sell-rating-by-wall-street-zen-2026-08-29/
CYTK Shares Slip 8% Despite Positive Phase 3 Aficamten Results In Non-Obstructive HCM
August 28, 2026  |  rttnews.comhttps://www.rttnews.com/3686508/cytk-shares-slip-8-despite-positive-phase-3-aficamten-results-in-non-obstructive-hcm.aspx
Cytokinetics boasts a first-ever in heart disease — and shares drop
August 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/cytokinetics-boasts-a-first-ever-in-heart-disease-and-shares-drop/ar-AA2b6xTL
Cytokinetics posts full data from late-stage trial for lead drug in non-obstructive HCM
August 28, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4637908-cytokinetics-posts-full-trial-data-lead-drug-nhcm
Cytokinetics, Incorporated (CYTK) Discusses Positive Phase III Results From ACACIA-HCM Trial of Aficamten in Nonobstructive HCM Transcript
August 28, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4941285-cytokinetics-incorporated-cytk-discusses-positive-phase-iii-results-from-acacia-hcm-trial-of
Cytokinetics (NASDAQ:CYTK) Shares Gap Down - Should You Sell?
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-cytokinetics-nasdaq-cytk-shares-gap-down-should-you-sell-2026-08-28/
--Cytokinetics Phase 3 Trial Shows Aficamten Improves Heart Disease Symptoms
August 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cytokinetics-phase-3-trial-shows-103046403.html
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England ...
August 28, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/cytokinetics-announces-positive-results-from-acacia-hcm-presented-in-hot-line-session-at-the-european-society-of-cardiology-esc-congress-2026-and-published-in-the-new-england-journal-of-medicine-1036502498
Cytokinetics eyes expanded use of heart drug after promising late-stage data
August 28, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/cytokinetics-eyes-expanded-use-heart-drug-after-promising-late-stage-data-2026-08-28/
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
August 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/28/3352576/35409/en/cytokinetics-announces-positive-results-from-acacia-hcm-presented-in-hot-line-session-at-the-european-society-of-cardiology-esc-congress-2026-and-published-in-the-new-england-journ.html
Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Rating of "Moderate Buy" by Analysts
August 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30981227
Cytokinetics, Incorporated (NASDAQ:CYTK) Given Average Rating of "Moderate Buy" by Analysts
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-cytokinetics-incorporated-nasdaq-cytk-given-average-rating-of-moderate-buy-by-analysts-2026-08-25/
Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700
August 22, 2026  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares-for-usd575-700/
Great Lakes Advisors LLC Acquires Shares of 23,002 Cytokinetics, Incorporated $CYTK
August 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-great-lakes-advisors-llc-acquires-shares-of-23002-cytokinetics-incorporated-cytk-2026-08-22/
Cytokinetics to Present ACACIA-HCM Hot Line Results and Host Investor Event at ESC Congress 2026
August 20, 2026  |  quiverquant.comQ
Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
August 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/20/3348261/35409/en/cytokinetics-announces-upcoming-presentations-at-the-european-society-of-cardiology-esc-congress-2026.html
Fady Ibraham Malik Sells 3,500 Shares of Cytokinetics (NASDAQ:CYTK) Stock
August 19, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-cytk-insider-buying-and-selling-2026-08-19/
Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells $265,370.00 in Stock
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-cytokinetics-nasdaqcytk-evp-sells-26537000-in-stock-2026-08-18/
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/18/3347210/35409/en/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
Cytokinetics (NASDAQ:CYTK) Raised to Hold at Wall Street Zen
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/cytokinetics-nasdaqcytk-raised-to-hold-at-wall-street-zen-2026-08-16/
J.P. Morgan Keeps Their Buy Rating on Cytokinetics (CYTK)
August 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3850253/j-p-morgan-keeps-their-buy-rating-on-cytokinetics-cytk/
Truist Financial Keeps Their Buy Rating on Cytokinetics (CYTK)
August 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CYTK/pressreleases/3843068/truist-financial-keeps-their-buy-rating-on-cytokinetics-cytk/
Cytokinetics (CYTK) Q2 2026 Earnings Call Transcript
August 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cytokinetics-cytk-q2-2026-earnings-223230205.html
Cytokinetics sues Bristol-Myers to avoid patent case
August 13, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/cytokinetics-sues-bristol-myers-to-avoid-patent-case/ar-AA2a2pn5
Cytokinetics sues Bristol-Myers to avoid patent dispute
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4632452-cytokinetics-sues-bristol-myers-in-patent-case
JPMorgan Chase & Co. Raises Cytokinetics (NASDAQ:CYTK) Price Target to $103.00
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-raises-cytokinetics-nasdaqcytk-price-target-to-10300-2026-08-13/
Cytokinetics, Incorporated $CYTK Shares Purchased by Tema ETFs LLC
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-cytokinetics-incorporated-cytk-shares-purchased-by-tema-etfs-llc-2026-08-13/
Handelsbanken Fonder AB Grows Stock Holdings in Cytokinetics, Incorporated $CYTK
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-handelsbanken-fonder-ab-grows-stock-holdings-in-cytokinetics-incorporated-cytk-2026-08-12/
Dimensional Fund Advisors LP Has $6.23 Million Stock Holdings in Cytokinetics, Incorporated $CYTK
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-has-623-million-stock-holdings-in-cytokinetics-incorporated-cytk-2026-08-12/
HC Wainwright Raises Earnings Estimates for Cytokinetics
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-raises-earnings-estimates-for-cytokinetics-2026-08-11/
Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells $575,700.00 in Stock
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-cytokinetics-nasdaqcytk-ceo-sells-57570000-in-stock-2026-08-10/
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Immunocore Holdings (IMCR)
August 10, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CYTK-Q/pressreleases/3757467/analysts-offer-insights-on-healthcare-companies-cytokinetics-cytk-and-immunocore-holdings-imcr/
Cytokinetics (CYTK) Gets a Buy from Evercore ISI
August 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/CYTK/pressreleases/3736228/cytokinetics-cytk-gets-a-buy-from-evercore-isi/

Cytokinetics Media Mentions By Week

Cytokinetics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTK
News Sentiment
▼
0.46

0.78
▲
Average
Healthcare
News Sentiment

Cytokinetics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTK Articles
This Week
▼
31

12
▲
CYTK Articles
Average Week

Cytokinetics Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
-75%
Page Views
3,882
+2%
Get Cytokinetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Cytokinetics dated 9/3/2026.
From Our Partners
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel